https://www.endohilfe.de/forschung/elagolix/
Elagolix – neue Generation von GnRH-Antagonisten – EndoHilfe
elagolixneuegenerationvongnrh
https://www.fiercebiotech.com/biotech/abbott-and-neurocrine-announce-global-agreement-to-develop-and-commercialize-elagolix-for-0
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the...
Jun 16, 2010 - ABBOTT PARK, Ill. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that they...
for theabbottneurocrineannounceglobal